Aroa is unlocking regenerative healing, accessability and affordabilityFind out more
Reinforced Bioscaffolds combine the best of biologics and synthetics to address the current shortcomings in surgical ventral hernia repair solutions.
Endoform Dermal Template is an intact extracellular matrix to treat acute and chronic wounds from Day One. Why wait for wounds to stall?
Our focus is delivering better healing, everyday, everywhere for everybody. We strive to make a meaningful impact for patients, surgeons and clinicians. We deliver high quality, simple to…Find out more
Auckland, April 12, 2018: New Zealand biomedical company Aroa Biosurgery has bought back the global marketing and distribution business for its Endoform wound care solutions after US healthcare company Hollister Incorporated decided to divest portions of its wound care business.Continue reading
Aroa Biosurgery has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s Endoform® Silver Dermal Template, which allows the company to market and sell this device in the USA.Continue reading
New Zealand biomedical company Aroa Biosurgery faces accelerating growth after a significant investment of up to US$25 million in its surgical partner for commercial expansion.